Associates of change in liver fat content in the morbidly obese after laparoscopic gastric banding surgery

Diabetes, Obesity and Metabolism

Volumn 10, Issue 8, 2008, Pages 661-667

  Phillips, Madeleine L ^a,b   Boase, S ^a   Wahlroos, S ^a,b   Dugar, M ^a   Kow, L ^a   Stahl, J ^c   Slavotinek, J P ^a   Valentine, R ^a   Toouli, J ^a,b   Thompson, C H ^a,b  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c Adelaide Pathology Partners   (Australia)

Author keywords

Liver fat; Magnetic resonance spectroscopy; Weight loss

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; FAT CONTENT; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LAPAROSCOPIC SURGERY; LIVER BIOPSY; MORBID OBESITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 47949130145     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2007.00793.x     Document Type: Article

References (41)

1. Clouston AD, Powell EE. Nonalcoholic fatty liver disease: Is all the fat bad? Intern Med J 2004; 34: 187-191.
2. Marceau P, Biron S, Hould FS et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84: 1513-1517.
3. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126: 137-145.
4. Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: An agenda for clinical research. Hepatology 2002; 35: 746-752.
5. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough, AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419.
6. Szczepaniak LS, Nurenberg P, Leonard D et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-E468.
7. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
8. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100.
9. Thomas EL, Hamilton G, Patel N et al. Hepatic triglyceride content and its relation to body adiposity: A magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005; 54: 122-127.
10. Busetto L, Tregnaghi A, De Marchi F et al. Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res 2002; 10: 408-411.
11. Mofrad P, Contos MJ, Haque M et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37: 1286-1292.
12. Sorrentino P, Tarantino G, Conca P, Terracciano ML, Vecchione R et al. Silent non-alcoholic fatty liver disease - a clinical-histological study. J Hepatol 2004; 41: 751-757.
13. Brunt EM, Neuschwander-Tetri BA, Oliver D, Wehmeier KR, Bacon BR. Nonalcoholic steatohepatitis: Histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol 2004; 35: 1070-1082.
14. Marchesini G, Brizi M, Bianchi G, Lenzi M et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
15. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 3023-3028.
16. Kral JG, Schaffner F, Pierson RN Jr, Wang J. Body fat topography as an independent predictor of fatty liver. Metabolism 1993; 42: 548-551.
17. Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 1991; 12: 224-229.
18. Luyckx FH, Desaive C, Thiry A et al. Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998; 22: 222-226.
19. Mottin CC, Moretto M, Padoin AV et al. Histological behaviour of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery. Obes Surg 2005; 15: 788-793.
20. Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology 2004; 39: 1647-1654.
21. Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. Fatty liver in type 2 diabetes mellitus: Relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003; 285: E906-E916.
22. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-1110.
23. Ross R, Leger L, Morris D, De Guise J, Guardo R. Quan.gification of adipose tissue by MRI: Relationship with anthropometric variables. J Appl Physiol 1992; 72: 787-795.
24. Ross R, Shaw K, Martel Y, de Guise J, Avruch L. Adipose tissue distribution measured by magnetic resonance imaging in obese women. Am J Clin Nutr 1993; 57: 470-475.
25. Abate N, Garg A, Coleman R, Grundy S, Peshock R. Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J Clin Nutr 1997; 65: 403-408.
26. Thomas EL, Bell JD. Influence of undersampling on magnetic resonance imaging measurements of intra-abdominal adipose tissue. Int J Obes 2003; 27: 211-218.
27. Longo R, Ricci C, Masutti F et al. Fatty infiltration of the liver. Quan.gification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993; 28: 297-302.
28. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O. Quan.gification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994; 12: 487-495.
29. Naressi A, Couturier C, Devos JM et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001; 12: 141-152.
30. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474.
31. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
32. Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000; 23: 57-63.
33. World Health Organisation. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. In: World Health Organisation Technical Report Series WHO, Genera 2000; i-xii.
34. Gavin J, Alberti K, Davidson M et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26: S5-S20.
35. Prati D, Taioli E, Zanella A et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-10.
36. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001; 21: 17-26.
37. Powell E, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
38. Marchesini G, Natale S, Manini R, Agostini F. Review article: The treatment of fatty liver disease associated with the metabolic syndrome. Aliment Pharmacol Ther 2005; 22(Suppl. 2): 37-39.
39. Wahlroos S, Phillips ML, Lewis MC et al. Rapid significant weight loss and regional lipid deposition: Implications for insulin sensitivity. Obes Res Clin Pract 2007; 1: 7-16.
40. Nomura F, Ohnishi K, Ochiai T, Okuda K. Obesity-related nonalcoholic fatty liver: CT features and follow-up studies after low-calorie diet. Radiology 1987; 162: 845-847.
41. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: Falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 2006; 16: 1278-1286.